These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23677008)

  • 1. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis.
    Rigottier-Gois L
    ISME J; 2013 Jul; 7(7):1256-61. PubMed ID: 23677008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
    Henson MA; Phalak P
    BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision editing of the gut microbiota ameliorates colitis.
    Zhu W; Winter MG; Byndloss MX; Spiga L; Duerkop BA; Hughes ER; Büttner L; de Lima Romão E; Behrendt CL; Lopez CA; Sifuentes-Dominguez L; Huff-Hardy K; Wilson RP; Gillis CC; Tükel Ç; Koh AY; Burstein E; Hooper LV; Bäumler AJ; Winter SE
    Nature; 2018 Jan; 553(7687):208-211. PubMed ID: 29323293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal dysbiosis in inflammatory bowel disease.
    Kaur N; Chen CC; Luther J; Kao JY
    Gut Microbes; 2011; 2(4):211-6. PubMed ID: 21983063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bidirectional Interactions between Resveratrol and Gut Microbiota: An Insight into Oxidative Stress and Inflammatory Bowel Disease Therapy.
    Hu Y; Chen D; Zheng P; Yu J; He J; Mao X; Yu B
    Biomed Res Int; 2019; 2019():5403761. PubMed ID: 31179328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery.
    Kriss M; Hazleton KZ; Nusbacher NM; Martin CG; Lozupone CA
    Curr Opin Microbiol; 2018 Aug; 44():34-40. PubMed ID: 30036705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
    Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
    United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestine-Specific NHE3 Deletion in Adulthood Causes Microbial Dysbiosis.
    Xue J; Dominguez Rieg JA; Thomas L; White JR; Rieg T
    Front Cell Infect Microbiol; 2022; 12():896309. PubMed ID: 35719363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease.
    Chamorro N; Montero DA; Gallardo P; Farfán M; Contreras M; De la Fuente M; Dubois K; Hermoso MA; Quera R; Pizarro-Guajardo M; Paredes-Sabja D; Ginard D; Rosselló-Móra R; Vidal R
    Microb Cell; 2021 Sep; 8(9):223-238. PubMed ID: 34527721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbial basis of inflammatory bowel diseases.
    Dalal SR; Chang EB
    J Clin Invest; 2014 Oct; 124(10):4190-6. PubMed ID: 25083986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.
    Lee JY; Cevallos SA; Byndloss MX; Tiffany CR; Olsan EE; Butler BP; Young BM; Rogers AWL; Nguyen H; Kim K; Choi SW; Bae E; Lee JH; Min UG; Lee DC; Bäumler AJ
    Cell Host Microbe; 2020 Aug; 28(2):273-284.e6. PubMed ID: 32668218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.